 Randi Johnson
Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 9 | 2023 | 729 | 1.820 |
Why?
| | Diabetes Mellitus, Type 1 | 17 | 2023 | 3254 | 1.680 |
Why?
| | Autoimmunity | 12 | 2023 | 822 | 1.370 |
Why?
| | Diet | 6 | 2021 | 1072 | 1.200 |
Why?
| | DNA Methylation | 4 | 2021 | 498 | 0.940 |
Why?
| | Dinoprostone | 1 | 2022 | 186 | 0.770 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 313 | 0.720 |
Why?
| | Autoantibodies | 6 | 2022 | 1360 | 0.700 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 141 | 0.670 |
Why?
| | Metabolomics | 3 | 2021 | 538 | 0.670 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 97 | 0.650 |
Why?
| | Asthma | 2 | 2022 | 2066 | 0.650 |
Why?
| | Adolescent Health | 1 | 2019 | 38 | 0.640 |
Why?
| | Glutens | 4 | 2021 | 56 | 0.560 |
Why?
| | Lipid Metabolism | 1 | 2019 | 449 | 0.550 |
Why?
| | Schools | 1 | 2019 | 400 | 0.520 |
Why?
| | Rural Population | 1 | 2019 | 447 | 0.510 |
Why?
| | Precision Medicine | 3 | 2023 | 344 | 0.500 |
Why?
| | Sexual Behavior | 1 | 2019 | 440 | 0.490 |
Why?
| | Adolescent Behavior | 1 | 2019 | 480 | 0.460 |
Why?
| | Health Behavior | 1 | 2019 | 707 | 0.440 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2098 | 0.420 |
Why?
| | Risk Factors | 10 | 2023 | 8697 | 0.410 |
Why?
| | Biological Specimen Banks | 2 | 2023 | 95 | 0.400 |
Why?
| | Seroconversion | 2 | 2021 | 46 | 0.360 |
Why?
| | Eating | 3 | 2021 | 346 | 0.330 |
Why?
| | Child | 14 | 2023 | 18488 | 0.310 |
Why?
| | Case-Control Studies | 5 | 2023 | 3022 | 0.290 |
Why?
| | Female | 19 | 2022 | 59913 | 0.290 |
Why?
| | Genetic Predisposition to Disease | 5 | 2021 | 2125 | 0.290 |
Why?
| | Humans | 27 | 2023 | 115587 | 0.280 |
Why?
| | Celiac Disease | 2 | 2020 | 266 | 0.280 |
Why?
| | Child, Preschool | 10 | 2021 | 9133 | 0.270 |
Why?
| | Male | 15 | 2023 | 55949 | 0.250 |
Why?
| | Genome-Wide Association Study | 2 | 2021 | 1217 | 0.250 |
Why?
| | Oxylipins | 2 | 2023 | 27 | 0.230 |
Why?
| | Colorado | 3 | 2023 | 4113 | 0.230 |
Why?
| | Diet Surveys | 2 | 2021 | 78 | 0.230 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1087 | 0.220 |
Why?
| | Eicosanoids | 1 | 2022 | 55 | 0.200 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.190 |
Why?
| | Infant | 8 | 2021 | 7979 | 0.190 |
Why?
| | Nasal Mucosa | 1 | 2022 | 94 | 0.190 |
Why?
| | Pregnancy | 4 | 2021 | 5548 | 0.190 |
Why?
| | Breast Feeding | 2 | 2021 | 370 | 0.190 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 77 | 0.190 |
Why?
| | Dietary Sucrose | 1 | 2020 | 45 | 0.180 |
Why?
| | Sugars | 1 | 2020 | 29 | 0.180 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 133 | 0.180 |
Why?
| | Phospholipids | 1 | 2021 | 202 | 0.170 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 1918 | 0.170 |
Why?
| | Disease Progression | 3 | 2022 | 2418 | 0.170 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 526 | 0.170 |
Why?
| | Prospective Studies | 5 | 2023 | 6264 | 0.170 |
Why?
| | Thinness | 1 | 2019 | 87 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2019 | 220 | 0.160 |
Why?
| | Postpartum Period | 1 | 2021 | 281 | 0.160 |
Why?
| | Dietary Proteins | 1 | 2019 | 123 | 0.160 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 80 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 347 | 0.150 |
Why?
| | Vulnerable Populations | 1 | 2019 | 138 | 0.150 |
Why?
| | Guatemala | 1 | 2019 | 268 | 0.150 |
Why?
| | Pilot Projects | 1 | 2022 | 1377 | 0.150 |
Why?
| | Child Health | 1 | 2019 | 133 | 0.150 |
Why?
| | Health Surveys | 1 | 2019 | 446 | 0.140 |
Why?
| | Child Behavior | 1 | 2019 | 218 | 0.140 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4440 | 0.140 |
Why?
| | Vitamin D | 1 | 2019 | 341 | 0.140 |
Why?
| | Environmental Exposure | 1 | 2020 | 378 | 0.130 |
Why?
| | Risk-Taking | 1 | 2019 | 332 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 906 | 0.130 |
Why?
| | Pregnancy, Unplanned | 1 | 2015 | 33 | 0.130 |
Why?
| | Overweight | 1 | 2019 | 469 | 0.120 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 125 | 0.120 |
Why?
| | Contraceptive Agents, Female | 1 | 2015 | 65 | 0.120 |
Why?
| | Aged | 2 | 2023 | 19251 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 447 | 0.120 |
Why?
| | Safety-net Providers | 1 | 2015 | 96 | 0.120 |
Why?
| | Students | 1 | 2019 | 502 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4435 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1334 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2021 | 5077 | 0.110 |
Why?
| | Adolescent | 6 | 2023 | 17889 | 0.110 |
Why?
| | Health Promotion | 1 | 2019 | 693 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 986 | 0.100 |
Why?
| | Premature Birth | 1 | 2015 | 278 | 0.100 |
Why?
| | Young Adult | 3 | 2022 | 10470 | 0.100 |
Why?
| | CpG Islands | 2 | 2021 | 118 | 0.100 |
Why?
| | Insulin | 1 | 2020 | 2082 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3466 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4665 | 0.080 |
Why?
| | Adult | 3 | 2021 | 30718 | 0.060 |
Why?
| | Ascorbic Acid | 1 | 2023 | 112 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 58 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 532 | 0.050 |
Why?
| | Iodide Peroxidase | 1 | 2020 | 27 | 0.050 |
Why?
| | Origin of Life | 1 | 2020 | 9 | 0.050 |
Why?
| | Isotopes | 1 | 2020 | 26 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 46 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 157 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 76 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 268 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 79 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 684 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 746 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 124 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2019 | 142 | 0.040 |
Why?
| | Transglutaminases | 1 | 2019 | 144 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 485 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 238 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2020 | 343 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 415 | 0.040 |
Why?
| | Gestational Age | 1 | 2020 | 757 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 414 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1103 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 385 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2022 | 731 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 698 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1786 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 159 | 0.030 |
Why?
| | Family Planning Services | 1 | 2015 | 67 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2335 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 336 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2416 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3339 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1086 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 4944 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2015 | 771 | 0.020 |
Why?
| | Smoking | 1 | 2015 | 1457 | 0.020 |
Why?
| | Mice | 1 | 2022 | 15052 | 0.020 |
Why?
| | Animals | 1 | 2022 | 32102 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|